BioTelemetry's (BEAT) MCOT Patch Approved by U.S. FDA

Go back to BioTelemetry's (BEAT) MCOT Patch Approved by U.S. FDA

BioTelemetry, Inc. Announces FDA Approval of Its Next Generation Device, the MCOT™ Patch

July 26, 2016 8:30 AM EDT

MALVERN, Pa., July 26, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of its next generation Mobile Cardiac Outpatient Telemetry device, the MCOT Patch.  The MCOT Patch is a four-lead, two-channel system which provides the same best in class technology as the current MCOT, in a more convenient form factor.  The MCOT devices, through the use of a... More